Claims Analysis
Total Claims: 13
Claim 1
Independent Claim
136 words
A method of preventing epileptic seizures in a human or mammal subject susceptible to said seizures, comprising systemically administering to said subject a safe and effective amount of a compound of the formula: ##STR12## wherein (a) X is halo or hydrogen, and Y is a substituent selected from the group consisting of unsubstituted or halogen-substituted methyl, halo, nitro, amino, and methoxy; and (b) R is N(R 3 ) 2 , OR 1 N(R 3 ) 2 , N(R 2 )R 1 N(R 3 ) 2 , or N(R 2 )N(R 3 ) 2 ; where R 1 is C 1 -C 3 alkylene which is unsubstituted or substituted with C 1 -C 2 alkyl; R 2 is hydrogen or lower alkyl; and each R 3 is, independently, hydrogen or lower alkyl; or a pharmaceutically-acceptable salt thereof.
Claim 2
Independent Claim
136 words
A method of preventing epileptic seizures in a human or mammal subject susceptible to said seizures, comprising systemically administering to said subject a safe and effective amount of a compound of the formula: ##STR12## wherein (a) X is halo or hydrogen, and Y is a substituent selected from the group consisting of unsubstituted or halogen-substituted methyl, halo, nitro, amino, and methoxy; and (b) R is N(R 3 ) 2 , OR 1 N(R 3 ) 2 , N(R 2 )R 1 N(R 3 ) 2 , or N(R 2 )N(R 3 ) 2 ; where R 1 is C 1 -C 3 alkylene which is unsubstituted or substituted with C 1 -C 2 alkyl; R 2 is hydrogen or lower alkyl; and each R 3 is, independently, hydrogen or lower alkyl; or a pharmaceutically-acceptable salt thereof.
Claim 3
Dependent Claim
24 words
A method of preventing epileptic seizures in a human or mammal subject susceptible to said seizures, according to claim 1 wherein X is hydrogen.
Claim 4
Dependent Claim
24 words
A method of preventing epileptic seizures in a human or mammal subject susceptible to said seizures, according to claim 1 wherein X is halo.
Claim 5
Dependent Claim
25 words
A method of preventing epileptic seizures in a human or mammal subject susceptible to said seizures, according to claim 1 wherein Y is halosubstituted methyl.
Claim 6
Dependent Claim
24 words
A method of preventing epileptic seizures in a human or mammal subject susceptible to said seizures, according to claim 1 wherein Y is trifluoromethyl.
Claim 7
Dependent Claim
44 words
A method of preventing epileptic seizures in a human or mammal subject susceptible to said seizures, according to claim 1 wherein R is N(R 3 ) 2 , N(R 2 )R 1 N(R 3 ) 2 or N(R 2 )N(R 3 ) 2 .
Claim 8
Dependent Claim
30 words
A method of preventing epileptic seizures in a human or mammal subject susceptible to said seizures, according to claim 1 wherein R is OR 1 N(R 3 ) 2 .
Claim 9
Dependent Claim
54 words
A method of preventing epileptic seizures in a human or mammal subject susceptible to said seizures, according to claim 2, wherein R is 3-diethylamino-2,2-dimethylpropoxy and Y is selected from the group consisting of: para- and meta-fluoro, para- and meta-chloro, para- and meta-trifluoromethyl, meta-nitro, para- and meta-bromo, para- and meta-methoxy, para methyl, para-amino and ortho-chloro.
Claim 10
Dependent Claim
41 words
A method of preventing epileptic seizures in a human or mammal subject susceptible to said seizures according to claim 3 wherein R is 3-diethylamino-2,2-dimethylpropoxy and X and Y are the same substituent selected from the group consisting of chloro and fluoro.
Claim 11
Dependent Claim
46 words
A method of preventing epileptic seizures in a human or mammal susceptible to said seizures according to claim 8 wherein Y is selected from the group consisting of: para- and meta-fluoro, para- and meta-chloro, para- and meta-triflouromethyl, meta-nitro, para- and meta-bromo, para- and meta-methoxy, and para-methyl.
Claim 12
Independent Claim
31 words
A method of preventing epileptic seizures in a human or mammal subject susceptible to said seizures, comprising systemically administering to said subject a safe and effective amount of 3-diethylamino-2,2-dimethylpropyl 5-(p-trifluoromethylphenyl)-2-furoate hydrochloride.
Claim 13
Independent Claim
31 words
A method of preventing epileptic seizures in a human or mammal subject susceptible to said seizures, comprising systemically administering to said subject a safe and effective amount of 3-diethylamino-2,2-dimethylpropyl 5-(p-trifluoromethylphenyl)-2-furoate hydrochloride.